Published on in Vol 23, No 12 (2021): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34051, first published .
Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Authors of this article:

Paul Kudlow1 Author Orcid Image ;   Tashauna Brown2 Author Orcid Image ;   Gunther Eysenbach3 Author Orcid Image

Journals

  1. Nishikawa-Pacher A. Measuring serendipity with altmetrics and randomness. Journal of Librarianship and Information Science 2023;55(4):1078 View
  2. Saravudecha C, Na Thungfai D, Phasom C, Gunta-in S, Metha A, Punyaphet P, Sookruay T, Sakuludomkan W, Koonrungsesomboon N. Hybrid Gold Open Access Citation Advantage in Clinical Medicine: Analysis of Hybrid Journals in the Web of Science. Publications 2023;11(2):21 View
  3. Wang X, Gui H, Liu J. How authors evaluate the novelty of their articles: A comparative analysis of highlights in research articles. Journal of Information Science 2023 View
  4. Madhugiri V, Venkatesan S. Does Reader Engagement with Neurosurgery Journal Websites Correlate with the Number of Citations Received by Articles?. Neurology India 2024;72(2):352 View
  5. Liu H, Hu G, Li Y. The enhanced research impact of self‐archiving platforms: Evidence from bioRxiv. Journal of the Association for Information Science and Technology 2024;75(8):883 View
  6. Vieli M, Battilana B, Alamri A, Rabiei K, Lippa L, Karekezi C, Kolias A, Serra C, Regli L, Mathiesen T, Staartjes V. A randomized controlled trial of social media promotion in neurosurgical publishing. Neurosurgical Review 2024;47(1) View